BUZZ-"Broker Opinions" Observation: As growth drivers for artificial intelligence continue to increase, Wall Street’s attitude towards Marvell Electronics is becoming more positive.
路透社2026/10/07 10:36October 7 - Marvell Technology (MRVL.O) on Tuesday raised its fiscal 2028 revenue forecast to around $20 billions, beating Wall Street expectations, as surging artificial intelligence spending drives growing demand for the company’s custom data center chips. At least 11 analysts have raised their price targets; the median target price among 45 brokerages covering the stock is $325, according to Reuters data. Full speed ahead: Morgan Stanley (rated “Neutral”, target price $300) said the company's long-term targets are achievable in a potential $3 trillion AI infrastructure spending environment, but cautioned that the projected 55%-70% growth leaves almost no room for execution errors, setting a high bar for quarterly results. JPMorgan (“Overweight”, target price $360) noted: "The company is operating at full speed, and the upgraded outlook is not limited to a single product category or customer, but is supported by multiple growth drivers across the data center full stack.” TD Cowen (“Buy”, target price $350) stated that Marvell’s underlying growth momentum has fully shifted to its robust connectivity business, and the risks associated with its custom XPU projects have substantially eased. Melius Research (“Buy”, target price $445) believes that Marvell's market capitalization could reach $1 trillion if the company executes as planned. (For the convenience of non-English speakers, Reuters has automatically translated its report into several other languages. Due to possible errors in automated translation or the absence of required context, Reuters does not guarantee the accuracy of translated texts, which are provided only for reader convenience. Reuters assumes no liability for any damage or loss caused by use of the automated translation feature.)
October 7 - ** Marvell Technology (MRVL.O) on Tuesday raised its fiscal 2028 (link) revenue guidance to around $20 billion, above Wall Street expectations, as surging artificial intelligence spending is driving increased demand for the company’s custom data center chips.
** At least 11 analysts raised their price targets; among 45 brokerages covering the stock, the median price target is $325 — according to Reuters compiled data.
Full speed ahead
** Morgan Stanley (rating: “Neutral”, target price: $300) said that in a potential $3 trillion AI infrastructure spending environment, the company’s long-term goals are achievable, but warned that expected growth of 55%-70% leaves nearly no room for execution errors, setting a high bar for quarterly performance.
** JPMorgan (“Overweight”, target price: $360) stated: “The company is firing on all cylinders, and the guidance upgrade is not limited to one product category or customer, but is supported by several growth drivers across the data center full stack.”
** TD Cowen (rating: “Buy”, target price: $350) noted that Marvell’s fundamental growth drivers have completely shifted to its strong connectivity business, and that risks associated with its custom XPU project have been significantly alleviated.
** Melius Research (“Buy”, target price: $445) believes that if Marvell can deliver as planned, its market capitalization could reach $1 trillion.
(To assist non-English speakers, Reuters has automated the translation of its reports into several other languages. Because automated translation may contain errors or may not include the context required, Reuters does not guarantee the accuracy of automated translation. The automated translation is provided to assist readers only. Reuters accepts no responsibility for any damage or loss caused by the use of automated translation.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Kalshi Submits Proposal for Perpetual Oil Contracts to the CFTC

Google partners with Unity (U.US) to develop a next-generation gaming platform: Create games by simply speaking, no coding required
Google has formed a strategic partnership with Unity, planning to launch an integrated gaming platform within the year that allows for creation with natural language. Unity shares rose nearly 6% in pre-market trading, while Roblox dropped nearly 5%.
BUZZ - Halozyme shares rise after winning a case against Merck's injectable Keytruda in a Dutch court
October 7 – Halozyme (HALO.O) shares rose 1.4% pre-market to $111.24. Halozyme announced it had obtained an injunction from a Dutch court (link), prohibiting Merck MRK.N from manufacturing, selling, and importing subcutaneous Keytruda in eight European markets. The court determined that Merck had infringed Halozyme’s EP622 patent and rejected Merck’s claims that the patent was invalid. Halozyme stated that patients will still have access to the intravenous version of Keytruda, which is not affected by the injunction. As of the close of the previous trading day, HALO shares have risen 62% this year. (For non-English speakers, Reuters automatically translates its reports into several languages. Due to possible errors or missing context in automated translations, Reuters does not guarantee the accuracy of such translated texts, which are provided for readers’ convenience only. Reuters assumes no liability for any damages or losses caused by use of the automated translation function.)
BUZZ-KeyBanc upgrades Corteva rating to "Overweight"; stock price rises
On October 7, KeyBanc upgraded the rating of agricultural technology company Corteva Inc (CTVA.N) from "Sector Weight" to "Overweight." CTVA rose 1.6% in pre-market trading to $14.1. The brokerage pointed out that new product launches, cost reductions, and improvements in farmers' economic conditions will be strong growth drivers for 2028-2029. The company’s ample cash reserves enable it to flexibly fund growth initiatives, stock buybacks, and potential acquisitions. Out of 23 brokerages, 16 have given the stock a "Buy" or higher rating, and 7 have rated it "Hold." The median target price is $18. As of the previous trading day's close, the stock had gained 38.3% year to date.